$0.07 EPS Expected for Inovalon Holdings Inc (INOV)

September 28, 2017 - By Darrin Black

 $0.07 EPS Expected for Inovalon Holdings Inc (INOV)

Wall Street await Inovalon Holdings Inc (NASDAQ:INOV) to release earnings on November, 1. Analysts forecast EPS of $0.07, up exactly $0.03 or 75.00 % from 2014’s $0.04 EPS. The expected INOV’s profit could reach $10.20 million giving the stock 60.54 P/E in the case that $0.07 earnings per share is reported. After posting $0.07 EPS for the previous quarter, Inovalon Holdings Inc’s analysts now forecast 0.00 % EPS growth. The stock increased 1.80% or $0.3 during the last trading session, reaching $16.95. About 851,685 shares traded or 38.43% up from the average. Inovalon Holdings Inc (NASDAQ:INOV) has declined 28.38% since September 28, 2016 and is downtrending. It has underperformed by 45.08% the S&P500.

Inovalon Holdings Inc (NASDAQ:INOV) Ratings Coverage

Among 11 analysts covering Inovalon Holdings Inc (NASDAQ:INOV), 1 have Buy rating, 1 Sell and 9 Hold. Therefore 9% are positive. Inovalon Holdings Inc had 20 analyst reports since August 6, 2015 according to SRatingsIntel. As per Tuesday, October 25, the company rating was initiated by First Analysis. The stock of Inovalon Holdings Inc (NASDAQ:INOV) has “Underweight” rating given on Wednesday, March 30 by Morgan Stanley. The stock of Inovalon Holdings Inc (NASDAQ:INOV) earned “Overweight” rating by KeyBanc Capital Markets on Tuesday, August 16. On Monday, August 10 the stock rating was downgraded by Zacks to “Hold”. The stock has “Neutral” rating by Goldman Sachs on Thursday, August 4. The stock of Inovalon Holdings Inc (NASDAQ:INOV) has “Americas Conviction List” rating given on Tuesday, August 18 by Goldman Sachs. The stock of Inovalon Holdings Inc (NASDAQ:INOV) has “Hold” rating given on Tuesday, September 12 by KeyBanc Capital Markets. The firm earned “Equal-Weight” rating on Tuesday, September 12 by Morgan Stanley. PiperJaffray downgraded Inovalon Holdings Inc (NASDAQ:INOV) on Thursday, August 4 to “Underweight” rating. The stock of Inovalon Holdings Inc (NASDAQ:INOV) has “Overweight” rating given on Tuesday, March 29 by Pacific Crest.

Inovalon Holdings, Inc. is a technology company. The company has market cap of $2.47 billion. The Firm provides cloud platforms empowering a data-driven transformation from volume to value models to the healthcare industry. It has a 143.9 P/E ratio. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

More important recent Inovalon Holdings Inc (NASDAQ:INOV) news were published by: Seekingalpha.com which released: “Inovalon Holdings’ (INOV) CEO Keith Dunleavy on Q1 2017 Results - Earnings …” on May 04, 2017, also Globenewswire.com published article titled: “Amgen Enters Into Agreement With Inovalon and Avalere to Engage Value-Based …”, Nasdaq.com published: “Inovalon Holdings’ ONE Platform Chosen by UnitedHealthcare” on September 14, 2017. More interesting news about Inovalon Holdings Inc (NASDAQ:INOV) was released by: Nasdaq.com and their article: “Inovalon Holdings Inc. (INOV) Is Up Sharply On UnitedHealthcare News” with publication date: September 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com